Beriplex® P/N (Kcentra)

BIOLOGICAL2 trials

Sponsors

CSL Behring

Conditions

Acute Major BleedingBlood Coagulation DisordersReversal of Coagulopathy

Phase 3

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

CompletedNCT00708435

CSL BehringAcute Major Bleeding, Blood Coagulation Disorders

Start: 2008-06-30End: 2010-11-30Updated: 2014-02-03

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure

CompletedNCT00803101

CSL BehringReversal of Coagulopathy

Start: 2009-02-28End: 2013-02-28Updated: 2015-04-06

Related Papers

Effectiveness of Four-Factor Prothrombin Complex Concentrate Versus Plasma in Patients on Vitamin K Antagonists Undergoing Urgent Orthopedic Surgery: A Post Hoc Analysis.

2026-03-30

Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal.

2015-07-0143 citations

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.

2015-02-27293 citations

Randomized Phase IIIb study of rapid vitamin K antagonist reversal in patients requiring an urgent surgical procedure: four-factor prothrombin complex concentrate is superior to plasma

2014-01-203 citations

Randomized Phase IIIb Study Of Rapid Vitamin K Antagonist Reversal In Patients Requiring An Urgent Surgical Procedure: Four-Factor Prothrombin Complex Concentrate Is Superior To Plasma

Blood2013-11-1510 citations

Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding

Circulation2013-08-10785 citations